chevron_leftBack
As of 13 June 2026, MindWalk Holdings Corp. has a market cap of $59.1M USD, ranking #29359 globally and #4347 in the United States.
It ranks #2657 in the Healthcare sector, and #510 in the Biotechnology industry.
Key Stats
Market Cap
$59.1MUSD
Enterprise Value
$53.81MUSD
Revenue (TTM)
$20.7MUSD
EBITDA (TTM)
-$7.73MUSD
Net Income (TTM)
-$9.03MUSD
EBITDA Margin
-37%
Profit Margin
-44%
PS Ratio
3.0
PB Ratio
5.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer Bath
open_in_new
Employees
102
Founded
1983
IPO
03 Jan 2017
Website
mindwalkai.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4% | -8.1% | 12% | -41% | -27% | 159% |
News
Loading...
HYFT Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
HYFT
MindWalk Holdings Corp
ISIN: CA6026871054
Shares Out.:
Shares Outstanding:
46.712M1
Shares Float:
42.355M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
1.19 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About MindWalk Holdings Corp.
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
309K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
270K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
47K%
|
-
|
|
NYSE: IQV
|
$26.3B
44K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
42K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
31K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
81K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
76K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
72K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
71K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
47K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
43K%
|
-
|
chevron_leftBack